Prescription drug · ANDA
Brivaracetam NDC 76282-825
Brivaracetam 75 mg/1 · Tablet, Film coated · Oral · Exelan Pharmaceuticals, Inc
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Brivaracetam
- Generic name (nonproprietary)
- brivaracetam
- Active ingredients
- Brivaracetam — 75 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Exelan Pharmaceuticals, Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 219952
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 76282-825_4e622d80-7a5d-47e4-9346-9509be1a2649SPL ID 4e622d80-7a5d-47e4-9346-9509be1a2649SPL set ID bf372f42-cfc9-4fcf-8226-3936ba8833d7RxCUI 1739761, 1739768, 1739772, 1739776, 1739780UNII U863JGG2IAUPC 0376282824604, 0376282822600, 0376282825601, 0376282823607
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 219952
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-823 |
| brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, Inc. | 50228-558 |
| brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, Inc. | 50228-556 |
| Brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-822 |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, Inc. | 50228-557 |
| Brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-824 |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, Inc. | 50228-559 |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals, Inc. | 50228-560 |
| Brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | Exelan Pharmaceuticals, Inc | 76282-826 |